October 8, 2025

Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This review unpacks current and emerging biomarkers in Alzheimer's disease, highlighting diagnostic criteria and clinical implications.

Recent technological advancements have enhanced the diagnosis of alzheimer's disease, improving treatment strategies.
Cerebrospinal fluid biomarkers and imaging methods are now standard tools for identifying early-stage alzheimer's disease.
Revised diagnostic criteria integrating biomarker-based assessments and clinical stages are set to formalize in 2024.
Emerging blood-based biomarkers offer promising, less invasive options for the early detection of alzheimer's disease.

Ishiguro et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark